<DOC>
	<DOCNO>NCT02952001</DOCNO>
	<brief_summary>The purpose study characterize continued clinical benefit ( ) regard safety efficacy suprachoroidally administer CLS-TA , triamcinolone acetonide injectable suspension , treatment macular edema associate non-infectious uveitis . This study non-interventional extension Parent study , CLS1001-301 .</brief_summary>
	<brief_title>Extension Study Patients With Non-infectious Uveitis Who Participated CLS1001-301</brief_title>
	<detailed_description>This non-interventional extension study 6 month subject complete Parent study . The Parent study Phase 3 , multicenter study assess safety efficacy 4 mg CLS-TA administer via suprachoroidal injection compare sham procedure treatment subject macular edema associate non-infectious uveitis . The study design Extension study include 4 clinic visit maximum 24 week . Subject eligibility establish Visit 1 crossover day Parent study extension study ( Day 0 ) . Follow-up visit conduct every 6 week 24 week ( Visit 4 ) . At Visit 4 , subject final evaluation conduct 24 week follow study entry ( 48 week Parent study randomization ) .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Panuveitis</mesh_term>
	<mesh_term>Uveitis , Posterior</mesh_term>
	<mesh_term>Uveitis , Intermediate</mesh_term>
	<mesh_term>Pars Planitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<criteria>Enrolled Parent study , CLS1001301 , Visit 8/Month 6 Willing able provide write informed consent prior study procedure ; willing comply instruction attend schedule study visit Received additional therapy treatment uveitis prohibit medication Require additional therapy treatment uveitis prohibit medication time Crossover visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>UME</keyword>
	<keyword>Posterior Uveitis</keyword>
	<keyword>Anterior Uveitis</keyword>
	<keyword>Intermediate Uveitis</keyword>
	<keyword>Panuveitis</keyword>
	<keyword>Non-infectious Uveitis</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Choroid</keyword>
	<keyword>Choroidal Injection</keyword>
	<keyword>Suprachoroidal</keyword>
	<keyword>Microneedle</keyword>
	<keyword>Microinjection</keyword>
</DOC>